Oryzon Genomics SA (ORY) — Capital Reinvestment Ratio
Oryzon Genomics SA (ORY) has a Capital Reinvestment Ratio of 0.17x as of December 2015, meaning it reinvests 0% of its operating cash flow (€523.10K) in capital expenditures (€87.70K). Check Oryzon Genomics SA tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oryzon Genomics SA Capital Reinvestment Ratio (2013–2015)
This chart tracks Oryzon Genomics SA's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see ORY cash flow conversion.
Annual Capital Reinvestment Ratio for Oryzon Genomics SA (2013–2015)
Year-by-year Capital Reinvestment Ratio for Oryzon Genomics SA from 2013 to 2015. See how much free cash does Oryzon Genomics SA generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.17x | €523.14K | €87.65K | ▲ +4222.7% |
| 2014 | 0.00x | €12.13 Million | €47.00K | ▼ -0.6% |
| 2013 | 0.00x | €12.13 Million | €47.30K | — |